Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Proton or Photon RT for Retroperitoneal Sarcomas

investigational therapy to use for further studies. "Investigational" means that the intervention is still being studied and that research doctors are trying to find out more about it. Retroperitoneal

  • 10 views
  • 25 Jan, 2021
  • 10 locations
Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)

A Phase 2 study of nivolumab plus ipilimumab in previously treated classical Kaposi Sarcoma (CKS)

  • 0 views
  • 22 Jan, 2021
  • 1 location
A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer

This study is a Phase Ib/II, open-label, multicenter clinical trial. Here, the study phase Ib is mainly to evaluate safety of combination regimen of Toripalimab and Cetuximab in treatment of relapsed or metastatic HNSCC failing first-line platinum-based therapy and determine the recommended Phase II dose (RP2D); the study phase II …

  • 0 views
  • 01 May, 2022
  • 1 location
A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

suggest that patritumab deruxtecan constitutes a promising investigational therapy for patients with EGFRm NSCLC.

  • 0 views
  • 06 May, 2022
  • 1 location
Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

allogeneic transplantation
cancer
  • 0 views
  • 13 May, 2022
  • 6 locations
Niraparib in Patients With Pancreatic Cancer

This research study is studying an investigational therapy as a possible treatment for pancreatic cancer. The drugs involved in this study are: -Niraparib

pancreatic adenocarcinoma
unresectable pancreatic cancer
palb2
antineoplastic
platelet count
  • 61 views
  • 20 Apr, 2022
Multi-antigen T Cell Infusion Against Neuro-oncologic Disease (REMIND)

/progressive/refractory CNS tumors): The first TAA-T dose will be infused any time 14 days or more after completing most recent course of conventional (non-investigational) therapy for their disease AND after

cns neoplasm
cancer
medulloblastoma
nervous
residual tumor
  • 4 views
  • 01 Feb, 2022
  • 1 location
Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

A Phase II study to assess the safety and efficacy of AVB-114 in treatment of complex Crohn's perianal fistulas in subjects with quiescent rectal disease and whose fistula has failed to respond to biologic or conventional therapy. Combined remission of treated perianal fistula in the investigational treatment arm will be …

remission
conventional treatment
  • 0 views
  • 30 Apr, 2022
  • 2 locations
Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection

Current management of COVID-19 (coronavirus) is mainly supportive, and respiratory failure from acute respiratory distress syndrome (ARDS) is the leading cause of mortality. Cytokines and chemokines are thought to play an important role in immunity and immunopathology during virus infections. Patients with severe COVID-19 have higher serum levels of pro-inflammatory …

  • 0 views
  • 02 Feb, 2021
  • 1 location
A Study of Melphalan, BCNU, Vitamin B12b, Vitamin C, and Stem Cell Infusion in People With Advanced Pancreatic Cancer and BRCA Mutations

The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on pancreatic cancer in patients who have an inherited, deleterious BRCA1 or BRCA2 genetic alteration. The investigational treatment will involve 2 cycles of a combination of intravenous melphalan, BCNU, low-dose I.V. ethanol, …

  • 14 views
  • 26 Apr, 2022
  • 2 locations